U.S. flag

An official website of the United States government

NM_000540.2(RYR1):c.1840C>T (p.Arg614Cys) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jun 16, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000119586.2

Allele description

NM_000540.2(RYR1):c.1840C>T (p.Arg614Cys)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.2(RYR1):c.1840C>T (p.Arg614Cys)
HGVS:
  • NC_000019.10:g.38457545C>T
  • NG_008866.1:g.28846C>T
  • NM_000540.2:c.1840C>T
  • NP_000531.2:p.Arg614Cys
  • LRG_766t1:c.1840C>T
  • LRG_766:g.28846C>T
  • LRG_766p1:p.Arg614Cys
  • NC_000019.9:g.38948185C>T
  • P21817:p.Arg614Cys
  • p.(Arg614Cys)
  • r.(?)
Protein change:
R614C; ARG614CYS
Links:
UniProtKB: P21817#VAR_005597; OMIM: 180901.0001; dbSNP: rs118192172
GMAF:
0.0002(T), 118192172
NCBI 1000 Genomes Browser:
rs118192172
Allele Frequency:
0.0001, GO-ESP
Molecular consequence:
  • NM_000540.2:c.1840C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000154493Leiden Muscular Dystrophy (RYR1)
no classification provided
not providedunknownnot provided

PubMed (1)
[See all records that cite this PMID]

SCV000329611GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Jun 16, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownnot providednot providednot providednot provided1not providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.

Gillies RL, Bjorksten AR, Davis M, Du Sart D.

Anaesth Intensive Care. 2008 May;36(3):391-403.

PubMed [citation]
PMID:
18564801

Details of each submission

From Leiden Muscular Dystrophy (RYR1), SCV000154493.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

From GeneDx, SCV000329611.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The R614C missense variant in the RYR1 gene has been reported previously in multiple individuals with malignant hyperthermia susceptibility (MHS) (Carpenter et al., 2009; Gillard et al., 1991; Gonsalves et al., 2013; Otsu et al., 1994; Vladutiu et al., 2011; Yang et al., 2003). R614C has also been classified as pathogenic multiple times in the RYR1 Leiden Open Variation Database (LOVD) and the ClinVar database. Additionally, different missense variants at the same position (R614L) and in a nearby residue (A612T) have been reported in the Human Gene Mutation Database in association with malignant hyperthermia (Quane et al., 1997; Stenson et al., 2014; Tong et al., 1997; Tong et al., 1999). R614C was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The R614C pathogenic variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Based on the ACMG recommendations, R614C is interpreted as a known pathogenic sequence change.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 11, 2017